Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mysterious Amazon/Berkshire/JPMorgan Partnership Could Disrupt Health Care, Pharma

Executive Summary

The collective bargaining power of the three large employers, potentially assisted by Amazon's low-cost distribution channels, could be a formidable force in negotiating lower cost and better quality health care services, including pharmaceutical products.


Related Content

Scrip Asks… What Does 2019 Hold For Biopharma? Part 2: Business Trends
Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack
Business As Usual Is Not A Vision For The Future – The Value-Based Shift Is Underway
Amazon And The Case For Major Health Care Disruption
Digital Deals And Life Sciences: Avoiding Death By A Thousand Pilots
Cigna/Express Scripts: The End Of The Standalone PBM Era
Deal Watch: Sanofi Finds Ideal 'Partner' For Leukine
J&J Shows Grace Under Pressure From Biosimilars And Other Threats
Amazon's Medtech Retail Plans: Analyst Finds More Evidence
Large Employer Drug Contracting Block Could Challenge Manufacturers, PBMs


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts